PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi

作者：J.W. Goldman, A. Passaro, J. Laskin, D. Rodrigues-Abreu, Antonio Calles, L. Bazhenova, Giuseppe Lo Russo, N. Leighl, F. Cappuzzo, N. Girard, S. Popat, Weizhen Fang, Ying Luo, Rong Yang, Wenyu Li, Junmin Li, Lori Styles, Bruce Thompson, Lin Zhang, X. Le · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.09.017 · 被引用次数：15 · 研究领域：Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies